Table 1. Main characteristics of all studies included in the meta-analysis.
First author & Ref. No. | Study Type | Country | Ethnicity | Control | Cases | Type | MBL2 gene variants/SNPs | Methods | Association |
---|---|---|---|---|---|---|---|---|---|
Wu et al.11 | CC | China | Asian | 453 | 151 | PTB | P > Q, Y > X, H > L, A > B | PCR-RFLP | No |
Chen et al.12 | CC | China | Asian | 419 | 503 | TB | Y > X, | PCR-SSP | Yes |
Chen et al.13 | CC | China | Asian | 216 | 205 | TB | Y > X, | PCR-SSP | Yes |
Garcia et al.14 | CC | Spain | Caucasian | 106 | 76 | PTB, EPTB | A > O | PCR-SSP | No |
Heidi et al.15 | CC | Brazil | Mixed | 148 | 155 | PTB, EPTB | H > L, Y > X, A > O, A > D, A > B, A > C | Sequencing | A > O, A > C risk |
Araujo et al.16 | CC | Brazil | Mixed | 159 | 167 | PTB, EPTB | A > B, A > C, A > D, A > O | PCR | No |
Singla et al.17 | CC | India | Asian | 392 | 357 | PTB, EPTB | A > B | PCR-RFLP | Yes |
Thye et al.18 | CC | Ghana | African | 2346 | 2230 | PTB | H > L, Y > X, P > Q, A > C | Pyrosequencing | A > C |
de Wit et al.19 | CC | South Africa | African | 318 | 505 | TB | A>B, A > D, A > C | PCR-RFLP ARMS-PCR | No |
Capparelli et al.20 | CC | Italy | Caucasian | 288 | 277 | PTB | A > O | PCR | Protective |
Cossar et al.21 | CC | Turkey | Caucasian | 44 | 99 | PTB, EPTB | A > B | PCR-RFLP | Protective |
Alagarasu et al.22 | CC | India | Asian | 146 | 366 | HIV + PTB, EPTB | A > B, A > D, A > C, A > O, Y > X | PCR-SSP | Y > X, A > O |
Soborg et al.23 | CC | Tanzania | African | 426 | 443 | PTB | A > B, A > D, A > C, A > O | PCR-RFLP | No |
Liu et al.24 | CC | China | Asian | 293 | 152 | PTB | H > L, P > Q, Y > X, A > B | PCR-SSP | No |
Garcia et al.25 | CC | Spain | Caucasian | 344 | 127 | TB | A > O | PCR-RFLP PCR-SSP | No |
Selvaraj et al.26 | CC | India | Asian | 58 | 48 | PTB | A > O | PCR-SSOP | No |
Fitness et al.27 | CC | Malawi | African | 546 | 322 | HIV+−TB | A > C | F-PCR ARMS-PCR | Yes |
Soborg et al.28 | CC | Denmark | Mixed | 250 | 109 | TB | A > O, A > B, A > D, A > C | PCR-SSP | No |
Ozbaş et al.29 | CC | Turkey | Caucasian | 100 | 49 | PTB | A > B | PCR | No |
Selvaraj et al.30 | CC | India | Asian | 109 | 202 | PTB | A > B, A > C, A > D, A > O | PCR | A > C |
Hoal et al.31 | CC | South Africa | African | 79 | 155 | PTB, Meningeal TB | A > B, A > C, A > D | PCR-RFLP | Protective A > B |
Bellamy et al.32 | CC | Gambia | African | 422 | 397 | PTB | A > B, A > C | PCR | Protective A > C |
Note: *MBL2 gene variants designated as: rs1800451 (A > C), rs1800450 (A > B), rs5030737 (A > D), rs7096206 (Y > X), rs11003125 (H > L), rs7095891 (P > Q), Combined rs1800450, rs1800451, rs5030737 (A > O).
**CC = Case-control study; TB = Tuberculosis; PTB = Pulmonary tuberculosis; EPTB = Extrapulmonary tuberculosis; HIV = Human immunodeficiency virus.